SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,586.00    58.00 (1.28%)
Bid:
4,568.00
Ask:
4,572.00
Spread: 4.00 (0.088%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

25 Sep 2020 10:09

RNS Number : 1473A
Coca-Cola HBC AG
25 September 2020
 

 

 

FOR IMMEDIATE RELEASE

 

 

Coca-Cola HBC AG

Director Declaration

 

 

Zug, Switzerland - 25 September 2020 - Coca-Cola HBC AG (the "Company") has been notified that Olusola (Sola) David-Borha, independent Non-Executive Director of the Company, has been appointed a Non-Executive Director of Stanbic IBTC Holdings PLC, a company listed on the Nigerian Stock Exchange.

The appointment is effective from 24 September 2020, following receipt of all regulatory approvals.

This notification is made in accordance with the Financial Conduct Authority's Listing Rule 9.6.14R(2).

 

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary +41 (0) 41 726 01 10

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused CPG business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the societies in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve more than 600 million consumers across a broad geographic footprint of 28 countries on 3 continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading partner brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These brands include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Royal Bliss, Costa Coffee, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our more than 28,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGCGDCRGDDGGU
Date   Source Headline
11th Jul 20233:53 pmRNSNotice of Results
7th Jul 20237:00 amRNSTRADING UPDATE
3rd Jul 20239:12 amRNSDirector/PDMR Shareholding
3rd Jul 20238:32 amRNSIssue of equity and total voting rights
23rd Jun 20234:04 pmRNSDirector/PDMR Shareholding
21st Jun 202311:05 amRNSDirector/PDMR Shareholding
21st Jun 202310:46 amRNSDirector/PDMR Shareholding
19th Jun 20233:06 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSCCH to acquire Finlandia Vodka from Brown-Forman
1st Jun 202310:07 amRNSIssue of equity and total voting rights
25th May 20237:00 amRNSCoca-Cola HBC Investor Day
18th May 20232:50 pmRNSDirector/PDMR Shareholding
18th May 20232:46 pmRNSDirector/PDMR Shareholding
17th May 20233:44 pmRNSCCH - Board Committees Composition
17th May 20233:37 pmRNSResult of AGM
4th May 20232:43 pmRNSAthens Exchange trading date of ordinary shares
3rd May 20237:00 amRNSStrategic progress driving strong revenue growth
2nd May 202311:23 amRNSBlock listing Interim Review
2nd May 202310:38 amRNSIssue of equity and total voting rights
24th Apr 20232:03 pmRNSNotice of Results-NEW TIME for the analysts call
18th Apr 20232:46 pmRNSDirector/PDMR Shareholding
13th Apr 20238:41 amRNSNotice of AGM
3rd Apr 20233:14 pmRNSNotice of Results
3rd Apr 20232:52 pmRNSIssue of equity and total voting rights
31st Mar 20232:54 pmRNSDirector/PDMR Shareholding
31st Mar 202312:30 pmRNSDirector/PDMR Shareholding
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding
15th Mar 20232:38 pmRNSDirector/PDMR Shareholding
8th Mar 202310:46 amRNSHolding(s) in Company
7th Mar 202311:56 amRNSHolding(s) in Company
6th Mar 20233:29 pmRNSDirector/PDMR Shareholding
3rd Mar 20238:00 amRNSDirector/PDMR Shareholding
1st Mar 20232:11 pmRNSIssue of equity and total voting rights
28th Feb 20238:09 amRNSDirector/PDMR Shareholding
23rd Feb 20239:21 amRNSDirector/PDMR Shareholding
22nd Feb 20233:54 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:43 pmRNSDirector/PDMR Shareholding
20th Feb 20232:46 pmRNSDirector/PDMR Shareholding
20th Feb 20232:13 pmRNSDirector/PDMR Shareholding
16th Feb 202311:28 amRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSStrong execution drives another year of growth
1st Feb 20231:50 pmRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.